Natixis’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,026
| Closed | -$349K | – | 1413 |
|
|
2021
Q3 | $349K | Sell |
2,026
-16
| -0.8% | -$2.76K | ﹤0.01% | 1070 |
|
|
2021
Q2 | $256K | Sell |
2,042
-1,870
| -48% | -$234K | ﹤0.01% | 797 |
|
|
2021
Q1 | $531K | Sell |
3,912
-254
| -6% | -$34.5K | ﹤0.01% | 930 |
|
|
2020
Q4 | $533K | Buy |
+4,166
| New | +$533K | ﹤0.01% | 889 |
|
|
2020
Q3 | – | Sell |
-7,522
| Closed | -$717K | – | 911 |
|
|
2020
Q2 | $717K | Buy |
+7,522
| New | +$717K | 0.01% | 564 |
|
|
2019
Q2 | – | Sell |
-5,680
| Closed | -$256K | – | 944 |
|
|
2019
Q1 | $256K | Sell |
5,680
-3,118
| -35% | -$141K | ﹤0.01% | 741 |
|
|
2018
Q4 | $383K | Buy |
+8,798
| New | +$383K | ﹤0.01% | 600 |
|